2016 International Congress

Thursday, June 23, 2016

12:00pm-1:30pm

AMP kinase regulates ligand-gated K-ATP channels in substantia nigra dopamine neurons

S.W. Johnson, Y. Wu, A.C. Munhall, K.Z. Shen (Portland, OR, USA)

Neuropharmacology  ·  Exhibit Hall located in Hall B, Level 2

12:00pm-1:30pm

An atypical case of adult-onset, levodopa-responsive, paroxysmal dystonia

V.N. Holiday (Portland, OR, USA)

Dystonia  ·  Exhibit Hall located in Hall B, Level 2

12:00pm-1:30pm

An ongoing phase 2, multi-centre, open-label, study of WTX101 in Wilson disease patients – Early observations

A. Czlonkowska, K.H. Weiss, A. Ala, F. Askari, D. Nicholl, M.L. Schilsky (Warsaw, Poland)

Neuropharmacology  ·  Exhibit Hall located in Hall B, Level 2

12:00pm-1:30pm

An update on genotype-phenotype correlation in X-linked dystonia-parkinsonism (XDP/DYT3)

M.E. Dy, C.M. De Gusmao, M.E. Talkowski, T.J. Multhaupt-Buell, L.R. Paul, C. Bragg, N. Sharma (Boston, MA, USA)

Dystonia  ·  Exhibit Hall located in Hall B, Level 2

12:00pm-1:30pm

AntiParkinsonian effects of AG-0029 in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-treated macaque model of Parkinson’s disease

E.Y. Pioli, W.K.D. Ko, Q. Li, A. Crossman, E. Bezard, S. Hogg (Manchester, United Kingdom)

Neuropharmacology  ·  Exhibit Hall located in Hall B, Level 2

12:00pm-1:30pm

AntiParkinsonian effects of the “radiprodil and tozadenant” combination in MPTP-treated marmosets

A. Michel, J.M. Nicolas, S. Rose, M. Jackson, P. Colman, W. Briône, D. Sciberras, P. Muglia, D. Scheller, M. Citron, P. Downey (Braine L'Alleud, Belgium)

Pharmacology

12:00pm-1:30pm

AntiParkinsonian treatment patterns and motor complications among patients with Parkinson´s disease in Estonia

L. Kadastik-Eerme, N. Taba, P. Taba (Tartu, Estonia)

Parkinson's disease: Clinical trials, pharmacology and treatment  ·  Exhibit Hall located in Hall B, Level 2

12:00pm-1:30pm

Apomorphine treatment in advanced Parkinson’s disease (PD): Duration of treatment and safety experience in a managed care program in Germany

D. Maessen, G. Ebersbach, L. Timmermann, A. Ceballos-Baumann (Düsseldorf, Germany)

Parkinson's disease: Clinical trials, pharmacology and treatment  ·  Exhibit Hall located in Hall B, Level 2

12:00pm-1:30pm

Applicability study of a multitask cognitive and motor exercise program for individuals with Parkinson´s disease: The COGWEB CNS Move Program

J. Domingos, D. Peralta, R. Loureiro, C. Ribeiro, V.T. Cruz, J. Ferreira (Torres Vedras, Portugal)

Clinical trials and therapy in movement disorders  ·  Exhibit Hall located in Hall B, Level 2

12:00pm-1:30pm

Apraclonidine in blepharospasm

J. Jankovic, D. Vijayakumar, S. Wijemanne (Houston, TX, USA)

Dystonia  ·  Exhibit Hall located in Hall B, Level 2